MasterPharm LLC recalls Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPhar…
- Recall date
- April 14, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1269-2020
- FDA classification
- Class I
- Brand / firm
- MasterPharm LLC
- Sold / distributed
- Nationwide in the U.S.
Why it was recalled
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Get recall alerts
Free email alert whenever MasterPharm LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: MasterPharm LLC